Comparative pathogenesis of an avian H5N2 and a swine H1N1 influenza virus in pigs.
Pigs are considered intermediate hosts for the transmission of avian influenza viruses (AIVs) to humans but the basic organ pathogenesis of AIVs in pigs has been barely studied. We have used 42 four-week-old influenza naive pigs and two different inoculation routes (intranasal and intratracheal) to compare the pathogenesis of a low pathogenic (LP) H5N2 AIV with that of an H1N1 swine influenza virus. The respiratory tract and selected extra-respiratory tissues were examined for virus replication by titration, immunofluorescence and RT-PCR throughout the course of infection. Both viruses caused a productive infection of the entire respiratory tract and epithelial cells in the lungs were the major target. Compared to the swine virus, the AIV produced lower virus titers and fewer antigen positive cells at all levels of the respiratory tract. The respiratory part of the nasal mucosa in particular showed only rare AIV positive cells and this was associated with reduced nasal shedding of the avian compared to the swine virus. The titers and distribution of the AIV varied extremely between individual pigs and were strongly affected by the route of inoculation. Gross lung lesions and clinical signs were milder with the avian than with the swine virus, corresponding with lower viral loads in the lungs. The brainstem was the single extra-respiratory tissue found positive for virus and viral RNA with both viruses. Our data do not reject the theory of the pig as an intermediate host for AIVs, but they suggest that AIVs need to undergo genetic changes to establish full replication potential in pigs. From a biomedical perspective, experimental LP H5 AIV infection of pigs may be useful to examine heterologous protection provided by H5 vaccines or other immunization strategies, as well as for further studies on the molecular pathogenesis and neurotropism of AIVs in mammals.
De Vleeschauwer
Annebel
A
Laboratory of Virology, Faculty of Veterinary Medicine Ghent University, Merelbeke, Belgium.
Atanasova
Kalina
K
Van Borm
Steven
S
van den Berg
Thierry
T
Rasmussen
Thomas Bruun
TB
Uttenthal
Ase
A
Van Reeth
Kristien
K
D000818:Animals; D001483:Base Sequence; D017931:DNA Primers; D005455:Fluorescent Antibody Technique; D053118:Influenza A Virus, H1N1 Subtype / Q000472:pathogenicity*; D053125:Influenza A Virus, H5N2 Subtype / Q000472:pathogenicity*; D009976:Orthomyxoviridae Infections / Q000635:transmission / Q000821:virology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013552:Swine
D017931:DNA Primers
Arch Virol. 2006 Jul;151(7):1267-79
16502281
Hum Pathol. 2009 May;40(5):735-9
19121843
Microbes Infect. 2004 Aug;6(10):919-25
15310468
Can Vet J. 2000 Dec;41(12):938-9
11143928
J Virol. 2009 May;83(9):4205-15
19359528
J Gen Virol. 2005 Apr;86(Pt 4):1131-1139
15784907
Arch Virol. 1977;53(3):265-8
856111
Vet Microbiol. 2003 Aug 29;95(1-2):1-13
12860072
J Virol. 2001 Oct;75(20):9679-86
11559800
Arch Virol. 2009;154(4):677-81
19288052
J Virol. 2009 Feb;83(4):1572-8
19052090
J Gen Virol. 1994 Sep;75 ( Pt 9):2183-8
8077918
J Comp Pathol. 2007 Aug-Oct;137(2-3):155-9
17689552
Leg Med (Tokyo). 2004 Oct;6(4):252-5
15363451
Emerg Infect Dis. 2006 Apr;12(4):681-3
16704821
Vet Microbiol. 2008 Sep 18;131(1-2):82-92
18403137
Rev Med Virol. 2003 Mar-Apr;13(2):85-97
12627392
Emerg Infect Dis. 2004 Dec;10(12):2189-91
15663858
Pediatr Int. 2000 Apr;42(2):204-14
10804743
Vaccine. 2009 Apr 6;27(16):2258-64
19428840
J Virol. 2008 Jan;82(1):220-8
17942562
Vet Microbiol. 2002 Aug 25;88(2):107-14
12135631
Prev Vet Med. 2007 May 16;79(2-4):294-303
17223213
Infect Immun. 1981 Nov;34(2):354-61
7309229
Vet Microbiol. 2003 Apr 2;92(3):197-212
12523982
Emerg Infect Dis. 2006 Nov;12(11):1744-7
17283627
Lancet. 2007 Sep 29;370(9593):1137-45
17905166
J Virol. 2005 Aug;79(16):10821-5
16051873
J Virol. 2000 Sep;74(18):8502-12
10954551
Virology. 1998 Dec 20;252(2):331-42
9878612
J Virol. 1996 Nov;70(11):8041-6
8892928
PLoS Pathog. 2008 Jul 11;4(7):e1000102
18617994
Vet Res. 2007 Mar-Apr;38(2):243-60
17257572
J Clin Microbiol. 2004 Sep;42(9):4349-54
15365042
Vaccine. 2009 Oct 23;27(45):6330-9
19840669
Am J Pathol. 2007 Oct;171(4):1215-23
17717141
J Clin Microbiol. 2000 Nov;38(11):4096-101
11060074